Perspective
Why Widespread Testing for Alzheimer’s Is Essential
April 6, 2026
Featured Experts: Dana Goldman, PhD
Research
All Research Featured Research
Journal Article
Evaluating Evidence-Based Recruitment Strategies for Alzheimer’s Disease and Related Dementias Clinical Trial Research: A Literature Review
March 16, 2026
Featured Experts: Mireille Jacobson, PhD, Desi Peneva, MS, Phyllis Barkman Ferrell, DrPH, MBA, Maria-Alice Manetas, Rema Raman, PhD, Paul Aisen, MD, Dana Goldman, PhD
Can We Prevent Alzheimer’s Disease Within a Decade?
March 5, 2026
Featured Experts: Paul Aisen, MD, Dana Goldman, PhD
News
USC Initiative Awards Funding to Test AI-Driven Strategies to Accelerate Alzheimer’s Clinical Trials
January 20, 2026
Featured Experts: Dana Goldman, PhD, Paul Aisen, MD
Data Visualization
How Medical Costs for People with Dementia Are Changing Over Time and Across the U.S.
January 15, 2026
Featured Experts: Julie Zissimopoulos, PhD, Dana Goldman, PhD, Bryan Tysinger, PhD
Perspective
Money Alone Can’t Fix the ACA. Here’s How to Cover Everyone Without Increasing Costs.
December 3, 2025
Featured Experts: Dana Goldman, PhD
Comment Letter
Response to the Draft Report of the Health Economics Methods Advisory (HEMA): “Defining Appropriate Benefits for Economic Evaluation of Health Care Technologies”
October 21, 2025
Featured Experts: Alice Chen, PhD, Jason Doctor, PhD, Dana Goldman, PhD, Darius Lakdawalla, PhD, Barry Liden, JD, Karen Mulligan, PhD, Desi Peneva, MS, Charles E. Phelps, PhD
Evidence Base
A Value-Based Price for Anti-Obesity Medications
July 17, 2025
Featured Experts: Alison Sexton Ward, PhD, Dana Goldman, PhD
Journal Article
Proposal for a Value-Based Agreement to Reimburse Anti-Obesity Medicines in Traditional Medicare
July 11, 2025
Featured Experts: Alison Sexton Ward, PhD, Erin Trish, PhD, Dana Goldman, PhD, Darius Lakdawalla, PhD
Comment Letter
Comments to USTR on Foreign Nations Freeloading on American-Financed Innovation
June 27, 2025
Featured Experts: Dana Goldman, PhD, Darius Lakdawalla, PhD, Barry Liden, JD
Journal Article
Advancing the Science of Recruitment for Alzheimer’s Clinical Trials: Challenges and Opportunities
June 12, 2025
Featured Experts: Paul Aisen, MD, Desi Peneva, MS, Maria-Alice Manetas, Mireille Jacobson, PhD, Dana Goldman, PhD, Niranjan Bose, PhD, Phyllis Barkman Ferrell, DrPH, MBA, Rema Raman, PhD
Perspective
Ensuring Most-Favored Nation Drug Pricing Doesn’t Sicken Us
May 20, 2025
Featured Experts: Darius Lakdawalla, PhD, Dana Goldman, PhD
Evidence Base
Patients Win When NIH Swings for the Fences
May 1, 2025
Featured Experts: Dana Goldman, PhD, Bob Kocher, MD
News
U.S. Dementia Costs to Exceed $780 Billion This Year, USC-Led Research Finds
April 23, 2025
Featured Experts: Julie Zissimopoulos, PhD, Dana Goldman, PhD, Bryan Tysinger, PhD
Issue Brief
The Cost of Dementia in 2025
April 23, 2025
Featured Experts: Julie Zissimopoulos, PhD, Dana Goldman, PhD, Bryan Tysinger, PhD
Perspective
‘Most-Favored Nation’ Drug Pricing Has Three Significant Problems
April 14, 2025
Featured Experts: Darius Lakdawalla, PhD, Dana Goldman, PhD
Perspective
A Missed Chance to Make America Healthier and Richer
April 7, 2025
Featured Experts: Alison Sexton Ward, PhD, Dana Goldman, PhD
White Paper
Lifetime Social Returns From Expanding Access to Anti-Obesity Medications
March 27, 2025
Featured Experts: Alison Sexton Ward, PhD, Bryan Tysinger, PhD, PhuongGiang Nguyen, MSPH, Darius Lakdawalla, PhD, Dana Goldman, PhD
News
Analysis Finds Meaningful Impact on Pharmaceutical Innovation From Reduced Revenues
February 18, 2025
Featured Experts: Darius Lakdawalla, PhD, Dana Goldman, PhD, Karen Van Nuys, PhD